With increasing frequency over the past few years, optometrists across the country have gotten referrals from internists requesting baseline diabetic retinopathy (DR) screenings for patients about to start therapy with one of the glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists such as semaglutide (Ozempic, Novo Nordisk), tirzepatide (Mounjaro, Eli Lilly) and dulaglutide (Trulicity, Eli Lilly
Most patients on semaglutide or tirzepatide reach their goal weight within 1218 months
However, taking GLP-1 receptor agonists without appropriate exercise and significant protein intake can make this problematic
Protein especially from quality sources like fish, legumes, dairy, or plant-based powders can help stimulate GLP-1, supporting better blood sugar control and reducing enzymes that inactivate it (Hira et al., 2021)
"Both injectable and oral semaglutide achieve over 16% weight loss," says Garvey
economy can all be treated by treating the disease of diseases, Alexander said during Newsweeks event, and so were underestimating the cost of doing nothing, which is not zero. Not covering GLP-1s, is not a neutral financial position, either